Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-07 07:16 am Sale | 2023-12-31 | 13G | Warburg Pincus Capital Corporation I-A WPCA | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -1,800,000 (Position Closed) | Filing History |
| 2024-02-07 07:14 am Unchanged | 2023-12-31 | 13G | Live Oak Crestview Climate Acquisition Corp. LOCC | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-07 07:14 am Unchanged | 2023-12-31 | 13G | Investcorp India Acquisition Corp IVCA | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-07 07:13 am Unchanged | 2023-12-31 | 13G | CC Neuberger Principal Holdings III PRPC | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-07 07:11 am Unchanged | 2023-12-31 | 13G | SHUAA Partners Acquisition Corp I SHUA | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-07 07:09 am Purchase | 2023-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,623,984 9.990% | 1,370,156 (+109.28%) | Filing History |
| 2024-02-07 07:08 am Sale | 2023-12-31 | 13G | Perella Weinberg Partners PWP | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,814,843 6.320% | -648,994 (-18.74%) | Filing History |
| 2024-02-07 07:08 am Unchanged | 2023-12-31 | 13G | L Catterton Asia Acquisition Corporation LCAA | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-07 07:07 am Purchase | 2023-12-31 | 13G | NET Power Inc. NPWR | ADAGE CAPITAL PARTNERS GP L.L.C. | 713,148 1.000% | 713,148 (New Position) | Filing History |
| 2024-02-07 07:06 am Purchase | 2023-12-31 | 13G | 89bio, Inc. ETNB | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,225,000 4.480% | 532,451 (+14.42%) | Filing History |
| 2024-02-07 07:05 am Purchase | 2023-12-31 | 13G | Compass Therapeutics, Inc. CMPX | ADAGE CAPITAL PARTNERS GP L.L.C. | 9,880,000 7.750% | 2,668,200 (+37.00%) | Filing History |
| 2024-02-07 07:04 am Purchase | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,864,475 9.470% | 1,305,117 (+50.99%) | Filing History |
| 2024-02-07 07:02 am Purchase | 2023-12-31 | 13G | Annexon, Inc. ANNX | ADAGE CAPITAL PARTNERS GP L.L.C. | 5,645,761 7.150% | 1,450,000 (+34.56%) | Filing History |
| 2024-02-07 07:01 am Sale | 2023-12-31 | 13G | Kensington Capital Acquisition Corp. V KCGI | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -1,452,605 (Position Closed) | Filing History |
| 2024-02-07 07:00 am Purchase | 2023-12-31 | 13G | Aeva Technologies, Inc. AEVA | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,259,032 6.220% | 13,986 (+0.43%) | Filing History |
| 2024-02-05 5:09 pm Purchase | 2024-01-24 | 13G | Mereo BioPharma Group plc MREO | ADAGE CAPITAL PARTNERS GP L.L.C. | 50,250,000 7.170% | 50,250,000 (New Position) | Filing History |
| 2024-01-29 4:30 pm Purchase | 2024-01-17 | 13G | Shattuck Labs, Inc. STTK | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,577,705 5.470% | 2,577,705 (New Position) | Filing History |
| 2023-12-26 4:31 pm Purchase | 2023-12-14 | 13G | Veru Inc. VERU | ADAGE CAPITAL PARTNERS GP L.L.C. | 13,722,222 9.500% | 13,722,222 (New Position) | Filing History |
| 2023-12-21 4:30 pm Purchase | 2023-12-11 | 13G | Werewolf Therapeutics, Inc. HOWL | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,034,255 8.380% | 3,034,255 (New Position) | Filing History |
| 2023-11-27 4:10 pm Purchase | 2023-11-16 | 13G | Compass Therapeutics, Inc. CMPX | ADAGE CAPITAL PARTNERS GP L.L.C. | 7,211,800 5.660% | 7,211,800 (New Position) | Filing History |